Company Monitoring Page for Roche

latest headlines for company on cafepharma

New data shows Roche's Enspryng significantly reduces neuromyelitis optica spectrum disorder relapses
PM Live
Sat, 10/16/21 - 11:25 pm
Tags:
Roche, Enspryng, NMOSD
Roche's Tecentriq crosses the finish line first in adjuvant lung cancer, potentially kicking off gold rush
Endpoints
Fri, 10/15/21 - 10:37 pm
Tags:
Roche, Tecentriq, non-small cell lung cancer, FDA
Actemra shortage spills over to include Sanofi’s rival Kevzara
Pharmaforum
Tue, 10/12/21 - 11:45 pm
Tags:
Roche, Actemra, Sanofi, Kevzara, drug shortages
Alzheimer’s Drug Granted FDA Breakthrough Designation as Space Heats Up
BioSpace
Mon, 10/11/21 - 09:48 pm
Tags:
Roche, FDA, breakthrough therapy, Alzheimer's disease, gantenerumab
Roche's Gantenerumab Gets FDA Breakthrough Therapy Designation for Alzheimer's Disease
Marketwatch
Sat, 10/9/21 - 10:58 pm
Tags:
Roche, FDA, gantenerumab, Alzheimer's disease, breakthrough therapy
Can This Duo Outperform Merck and Ridgeback Biotherapeutics' COVID Treatment?
Motley Fool
Fri, 10/8/21 - 10:58 am
Tags:
COVID-19, Merck, Ridgeback Therapeutics, Roche, Atea Pharmaceuticals, AT-527, antivirals
J&J spends $100M upfront, with $1.2B in biobucks, to join Roche and Regeneron in bispecific blood cancer race
Fierce Biotech
Mon, 10/4/21 - 11:08 am
Tags:
JNJ, Xencor, biobucks, Roche, Regeneron, bispecific antibodies, blood cancers, plamotamab
Roche, Takeda and Pfizer notch top scores among rare disease patient advocacy groups
Fierce Pharma
Mon, 10/4/21 - 11:03 am
Tags:
patients, patient advocacy groups, Roche, Takeda, Pfizer, reputation
Genentech study reveals health equity perception gap between patients and doctors
Fierce Pharma
Mon, 09/27/21 - 11:03 am
Tags:
Roche, Genentech, physicians, patients, racial disparity
Roche builds evidence for Evrysdi’s benefits in younger SMA patients
Pharmaforum
Fri, 09/24/21 - 12:01 pm
Tags:
Roche, spinal muscular atrophy, Evrysdi
Roche's Foundation Medicine is getting a new 16-story home in Boston's Seaport District
Endpoints
Thu, 09/23/21 - 10:50 am
Tags:
Roche, Foundation Medicine, Boston
AstraZeneca, Daiichi Sankyo's ADC Enhertu blows away Roche's Kadcyla in second-line advanced breast cancer
Endpoints
Sat, 09/18/21 - 08:34 pm
Tags:
ESMO, AstraZeneca, Daiichi Sankyo, Enhertu, breast cancer, Roche
Merck fleshes out Keytruda win in first-line cervical cancer, adding more firepower to its early cancer push
Endpoints
Sat, 09/18/21 - 08:29 pm
Tags:
ESMO, Merck, Keytruda, Roche, Avastin, cervical cancer
ESMO: Exelixis lays out promising early Cabometyx combo data in prostate cancer, but key discrepancies persist
Fierce Pharma
Sat, 09/18/21 - 08:27 pm
Tags:
ESMO, Exelixis, Cabometyx, Roche, Tecentriq, clinical trials, prostate cancer
ESMO21: Roche’s giredestrant takes stage in battle of the oral SERDs
Pharmaforum
Fri, 09/17/21 - 11:36 am
Tags:
Roche, Giredestrant, Serds, breast cancer, ESMO, AstraZeneca, Faslodex
Citing 'less-than-optimal' outcomes for Roche's Evrysdi, Biogen launches high-dose Spinraza trial
Fierce Pharma
Thu, 09/16/21 - 10:52 am
Tags:
Biogen, Spinraza, SMA, Roche, Evrysdi, spinal muscular atrophy
Roche and Temedica Pilot Digital Companion for MS Patients
BioSpace
Wed, 09/15/21 - 10:18 pm
Tags:
Roche, Temedica, MS, multiple sclerosis, devices, mobile apps
From Pfizer to Argenx: A look at potential blockbusters awaiting FDA decisions this year
Fierce Pharma
Mon, 09/13/21 - 11:38 pm
Tags:
FDA, Pfizer, Argenx, UCB Pharma, Roche, efgartigimod, bimekizumab, faricimab, abrocitinib
Novo Nordisk, Roche see outsized threats from U.S. drug pricing talks: analysts
Fierce Pharma
Mon, 09/13/21 - 10:41 am
Tags:
Novo Nordisk, Roche, drug pricing
Biotech's 'founding father' and influential deal broker Fred Frank dies at 89
Endpoints
Mon, 09/13/21 - 10:31 am
Tags:
Fred Frank, Roche, Genentech, biotech

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.